Skip to main content

Table 2 Overview of assessment moments and outcome measurements

From: The CIPRUS study, a nurse-led psychological treatment for patients with undifferentiated somatoform disorder in primary care: study protocol for a randomised controlled trial

 

Instrument

Baseline (T0)

2 months (T1)

4 months (T2)

8 months (T3)

12 months (T4)

Primary outcomes

Physical functioning

PCS of RAND-36

x

x

x

 

x

Direct and indirect costs

Tic-P

x

 

x

x

x

Quality of life

EQ-5D-5L

x

x

x

x

x

Secondary outcomes

HRQoL

RAND-36 subscales

x

x

x

 

x

Anxiety and depression

HADS

x

x

x

 

x

Number/severity of symptoms

PHQ-15

x

x

x

 

x

Potential mediators

Health anxiety

Whitely Index

x

x

x

  

Illness perceptions

Brief IPQ

x

x

x

  

Cognitions and coping

CBRQ

x

x

x

  

Social problem-solving skills

SPSI-R:S

x

x

x

  

Mastery

Pearlin Mastery Scale

x

x

x

  

Working alliance

WAI-SFa

 

x

x

  
  1. PCS physical component summary score, RAND-36 RAND-36-item Health Survey, Tic-P Trimbos and iMTA questionnaire on Costs associated with Psychiatric Illness, EQ-5D-5L EuroQol 5D – 5 level version, HRQoL health-related quality of life, HADS Hospital Anxiety and Depression Scale, PHQ-15 Patient Health Questionnaire somatization scale, IPQ Illness Perception Questionnaire, CBRQ Cognitive and Behavioural Responses Questionnaire, SPSI-R:S Social Problem-solving Inventory Revised: Short Form, WAI-SF Working Alliance Inventory-Short Form
  2. aonly administered in the intervention group